Retinal Dystrophy clinical trials at UCSF
3 research studies open to eligible people
Retinal dystrophy is an eye disease that affects vision. UCSF is running studies to understand and treat this condition. One study is preparing for a new vision restoration method. Another study is looking at how a specific gene mutation affects the eyes over time.
EyeConic: Qualification for Cone-Optogenetics
open to all eligible people
This study aims to prepare for the first-in-human clinical trial of cone optogenetics vision restoration. As a first step, this worldwide multicenter ocular imaging study (EyeConic Study) is performed to identify eligible patients.
San Francisco, California and other locations
PRPF31 Mutation-Associated Retinal Dystrophy
open to eligible people ages 10 years and up
The purpose of this study is to characterize the natural history through temporal systemic evaluation of subjects identified with PRPF31 mutation-associated retinal dystrophy, also called retinitis pigmentosa type 11, or RP11. Assessments will be completed to measure and evaluate structural and functional visual changes including those impacting patient quality of life associated with this inherited retinal condition and observing how these changes evolve over time.
San Francisco, California and other locations
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants
open to eligible people ages 4 years and up
This is an international, multicenter study with two components: Registry - A standardized genetic screening and a prospective, standardized, cross-sectional clinical data collection - Enrollment is open to all genes on the RD Rare Gene List Natural History Study - A prospective, standardized, longitudinal Natural History Study - Enrollment opens gene-by-gene, based on funding and within-gene Registry enrollment The study objectives are as follows. Registry Objectives 1. Genotype Characterization 2. Cross-Sectional Phenotype Characterization (within gene) 3. Establish a Link to My Retina Tracker Registry (MRTR) 4. Ancillary Exploratory Studies - Pooling of Genes Natural History Study Objectives 1. Natural History (within gene) 2. Structure-Function Relationship (within gene) 3. Risk Factors for Progression (within gene) 4. Ancillary Exploratory Studies - Pooling of Genes
San Francisco, California and other locations
Our lead scientists for Retinal Dystrophy research studies include Jacque Duncan, MD.
Last updated: